Trial to investigate the pharmacokinetics of controlled-release afamelanotide.

Trial Profile

Trial to investigate the pharmacokinetics of controlled-release afamelanotide.

Not stated
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2011

At a glance

  • Drugs Afamelanotide (Primary)
  • Indications Erythropoietic protoporphyria
  • Focus Pharmacokinetics
  • Sponsors Clinuvel Pharmaceuticals
  • Most Recent Events

    • 12 Feb 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top